LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 20

Search options

  1. Article ; Online: Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.

    Wild, Sophia A / Cannell, Ian G / Nicholls, Ashley / Kania, Katarzyna / Bressan, Dario / Hannon, Gregory J / Sawicka, Kirsty

    eLife

    2022  Volume 11

    Abstract: Tumour heterogeneity is thought to be a major barrier to successful cancer treatment due to the presence of drug resistant clonal lineages. However, identifying the characteristics of such lineages that underpin resistance to therapy has remained ... ...

    Abstract Tumour heterogeneity is thought to be a major barrier to successful cancer treatment due to the presence of drug resistant clonal lineages. However, identifying the characteristics of such lineages that underpin resistance to therapy has remained challenging. Here, we utilise clonal transcriptomics with WILD-seq;
    MeSH term(s) Humans ; Mice ; Animals ; Drug Resistance, Neoplasm/genetics ; Nuclear Proteins ; Transcriptome ; Asparagine ; Transcription Factors ; Triple Negative Breast Neoplasms/pathology ; Taxoids/pharmacology ; Taxoids/therapeutic use
    Chemical Substances Nuclear Proteins ; Asparagine (7006-34-0) ; Transcription Factors ; taxane (1605-68-1) ; Taxoids
    Language English
    Publishing date 2022-12-16
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.80981
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy.

    Cannell, Ian G / Sawicka, Kirsty / Pearsall, Isabella / Wild, Sophia A / Deighton, Lauren / Pearsall, Sarah M / Lerda, Giulia / Joud, Fadwa / Khan, Showkhin / Bruna, Alejandra / Simpson, Kathryn L / Mulvey, Claire M / Nugent, Fiona / Qosaj, Fatime / Bressan, Dario / Dive, Caroline / Caldas, Carlos / Hannon, Gregory J

    Cell reports

    2023  Volume 42, Issue 8, Page(s) 112791

    Abstract: Vasculogenic mimicry (VM) describes the formation of pseudo blood vessels constructed of tumor cells that have acquired endothelial-like properties. VM channels endow the tumor with a tumor-derived vascular system that directly connects to host blood ... ...

    Abstract Vasculogenic mimicry (VM) describes the formation of pseudo blood vessels constructed of tumor cells that have acquired endothelial-like properties. VM channels endow the tumor with a tumor-derived vascular system that directly connects to host blood vessels, and their presence is generally associated with poor patient prognosis. Here we show that the transcription factor, Foxc2, promotes VM in diverse solid tumor types by driving ectopic expression of endothelial genes in tumor cells, a process that is stimulated by hypoxia. VM-proficient tumors are resistant to anti-angiogenic therapy, and suppression of Foxc2 augments response. This work establishes co-option of an embryonic endothelial transcription factor by tumor cells as a key mechanism driving VM proclivity and motivates the search for VM-inhibitory agents that could form the basis of combination therapies with anti-angiogenics.
    MeSH term(s) Humans ; Neovascularization, Pathologic/metabolism ; Cell Line, Tumor ; Immunotherapy
    Language English
    Publishing date 2023-07-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2023.112791
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: CPEB3-dependent increase in GluA2 subunits impairs excitatory transmission onto inhibitory interneurons in a mouse model of fragile X.

    Hwang, Jee-Yeon / Monday, Hannah R / Yan, Jingqi / Gompers, Andrea / Buxbaum, Adina R / Sawicka, Kirsty J / Singer, Robert H / Castillo, Pablo E / Zukin, R Suzanne

    Cell reports

    2022  Volume 39, Issue 10, Page(s) 110853

    Abstract: Fragile X syndrome (FXS) is a leading cause of inherited intellectual disability and autism. Whereas dysregulated RNA translation in Fmr1 knockout (KO) mice, a model of FXS, is well studied, little is known about aberrant transcription. Using single- ... ...

    Abstract Fragile X syndrome (FXS) is a leading cause of inherited intellectual disability and autism. Whereas dysregulated RNA translation in Fmr1 knockout (KO) mice, a model of FXS, is well studied, little is known about aberrant transcription. Using single-molecule mRNA detection, we show that mRNA encoding the AMPAR subunit GluA2 (but not GluA1) is elevated in dendrites and at transcription sites of hippocampal neurons of Fmr1 KO mice, indicating elevated GluA2 transcription. We identify CPEB3, a protein implicated in memory consolidation, as an upstream effector critical to GluA2 mRNA expression in FXS. Increased GluA2 mRNA is translated into an increase in GluA2 subunits, a switch in synaptic AMPAR phenotype from GluA2-lacking, Ca
    MeSH term(s) Animals ; Disease Models, Animal ; Fragile X Mental Retardation Protein/metabolism ; Fragile X Syndrome/genetics ; Interneurons/metabolism ; Mice ; Mice, Knockout ; RNA, Messenger/metabolism ; RNA-Binding Proteins/genetics ; Receptors, AMPA/metabolism ; Receptors, N-Methyl-D-Aspartate/metabolism ; Synapses/metabolism
    Chemical Substances Cpeb3 protein, mouse ; Fmr1 protein, mouse ; RNA, Messenger ; RNA-Binding Proteins ; Receptors, AMPA ; Receptors, N-Methyl-D-Aspartate ; Fragile X Mental Retardation Protein (139135-51-6)
    Language English
    Publishing date 2022-06-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2022.110853
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Dysregulation of mTOR signaling in neuropsychiatric disorders: therapeutic implications.

    Sawicka, Kirsty / Zukin, R Suzanne

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

    2011  Volume 37, Issue 1, Page(s) 305–306

    MeSH term(s) Animals ; Autistic Disorder/drug therapy ; Autistic Disorder/metabolism ; Fragile X Syndrome/drug therapy ; Fragile X Syndrome/metabolism ; Humans ; Mice ; Psychopharmacology/methods ; Signal Transduction/drug effects ; Signal Transduction/physiology ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; TOR Serine-Threonine Kinases/physiology
    Chemical Substances MTOR protein, human (EC 2.7.1.1) ; TOR Serine-Threonine Kinases (EC 2.7.1.1) ; mTOR protein, mouse (EC 2.7.1.1)
    Language English
    Publishing date 2011-12-13
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 639471-1
    ISSN 1740-634X ; 0893-133X
    ISSN (online) 1740-634X
    ISSN 0893-133X
    DOI 10.1038/npp.2011.210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: FMRP regulates mRNAs encoding distinct functions in the cell body and dendrites of CA1 pyramidal neurons.

    Hale, Caryn R / Sawicka, Kirsty / Mora, Kevin / Fak, John J / Kang, Jin Joo / Cutrim, Paula / Cialowicz, Katarzyna / Carroll, Thomas S / Darnell, Robert B

    eLife

    2021  Volume 10

    Abstract: Neurons rely on translation of synaptic mRNAs in order to generate activity-dependent changes in plasticity. Here, we develop a strategy combining compartment-specific crosslinking immunoprecipitation (CLIP) and translating ribosome affinity purification ...

    Abstract Neurons rely on translation of synaptic mRNAs in order to generate activity-dependent changes in plasticity. Here, we develop a strategy combining compartment-specific crosslinking immunoprecipitation (CLIP) and translating ribosome affinity purification (TRAP) in conditionally tagged mice to precisely define the ribosome-bound dendritic transcriptome of CA1 pyramidal neurons. We identify CA1 dendritic transcripts with differentially localized mRNA isoforms generated by alternative polyadenylation and alternative splicing, including many that have altered protein-coding capacity. Among dendritic mRNAs, FMRP targets were found to be overrepresented. Cell-type-specific FMRP-CLIP and TRAP in microdissected CA1 neuropil revealed 383 dendritic FMRP targets and suggests that FMRP differentially regulates functionally distinct modules in CA1 dendrites and cell bodies. FMRP regulates ~15-20% of mRNAs encoding synaptic functions and 10% of chromatin modulators, in the dendrite and cell body, respectively. In the absence of FMRP, dendritic FMRP targets had increased ribosome association, consistent with a function for FMRP in synaptic translational repression. Conversely, downregulation of FMRP targets involved in chromatin regulation in cell bodies suggests a role for FMRP in stabilizing mRNAs containing stalled ribosomes in this compartment. Together, the data support a model in which FMRP regulates the translation and expression of synaptic and nuclear proteins within different compartments of a single neuronal cell type.
    MeSH term(s) Animals ; Cell Body/physiology ; Dendrites/physiology ; Female ; Fragile X Mental Retardation Protein/genetics ; Gene Expression Regulation ; Male ; Mice ; Mice, Inbred C57BL ; Neuronal Plasticity/physiology ; Pyramidal Cells/classification ; Pyramidal Cells/physiology ; RNA, Messenger/genetics ; Transcriptome
    Chemical Substances RNA, Messenger ; Fragile X Mental Retardation Protein (139135-51-6)
    Language English
    Publishing date 2021-12-23
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.71892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice.

    Sawicka, Kirsty / Pyronneau, Alexander / Chao, Miranda / Bennett, Michael V L / Zukin, R Suzanne

    Proceedings of the National Academy of Sciences of the United States of America

    2016  Volume 113, Issue 41, Page(s) E6290–E6297

    Abstract: Fragile X syndrome (FXS) is the most common heritable cause of intellectual disability and a leading genetic form of autism. The Fmr1 KO mouse, a model of FXS, exhibits elevated translation in the hippocampus and the cortex. ERK (extracellular signal- ... ...

    Abstract Fragile X syndrome (FXS) is the most common heritable cause of intellectual disability and a leading genetic form of autism. The Fmr1 KO mouse, a model of FXS, exhibits elevated translation in the hippocampus and the cortex. ERK (extracellular signal-regulated kinase) and mTOR (mechanistic target of rapamycin) signaling regulate protein synthesis by activating downstream targets critical to translation initiation and elongation and are known to contribute to hippocampal defects in fragile X. Here we show that the effect of loss of fragile X mental retardation protein (FMRP) on these pathways is brain region specific. In contrast to the hippocampus, ERK (but not mTOR) signaling is elevated in the neocortex of fragile X mice. Phosphorylation of ribosomal protein S6, typically a downstream target of mTOR, is elevated in the neocortex, despite normal mTOR activity. This is significant in that S6 phosphorylation facilitates translation, correlates with neuronal activation, and is altered in neurodevelopmental disorders. We show that in fragile X mice, S6 is regulated by ERK via the "alternative" S6 kinase p90-ribosomal S6 kinase (RSK), as evidenced by the site of elevated phosphorylation and the finding that ERK inhibition corrects elevated RSK and S6 activity. These findings indicate that signaling networks are altered in the neocortex of fragile X mice such that S6 phosphorylation receives aberrant input from ERK/RSK. Importantly, an RSK inhibitor reduces susceptibility to audiogenic seizures in fragile X mice. Our findings identify RSK as a therapeutic target for fragile X and suggest the therapeutic potential of drugs for the treatment of FXS may vary in a brain-region-specific manner.
    MeSH term(s) Animals ; Cerebral Cortex/metabolism ; Cerebral Cortex/physiopathology ; DNA-Binding Proteins/metabolism ; Disease Models, Animal ; Epilepsy, Reflex/drug therapy ; Epilepsy, Reflex/etiology ; Epilepsy, Reflex/metabolism ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Fragile X Mental Retardation Protein/genetics ; Fragile X Mental Retardation Protein/metabolism ; Fragile X Syndrome/complications ; Mice ; Mice, Knockout ; Neurons/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphorylation ; Ribosomal Protein S6 Kinases, 90-kDa/antagonists & inhibitors ; Ribosomal Protein S6 Kinases, 90-kDa/metabolism ; Seizures/etiology ; Seizures/metabolism ; Signal Transduction ; Synapses/metabolism ; TOR Serine-Threonine Kinases/metabolism ; Transcription Factors/metabolism
    Chemical Substances DNA-Binding Proteins ; Elf4 protein, mouse ; Fmr1 protein, mouse ; Transcription Factors ; Fragile X Mental Retardation Protein (139135-51-6) ; Phosphatidylinositol 3-Kinases (EC 2.7.1.-) ; TOR Serine-Threonine Kinases (EC 2.7.1.1) ; Ribosomal Protein S6 Kinases, 90-kDa (EC 2.7.11.1) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2016-09-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1610812113
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Effect of varying molecular weight of dextran on acrylic-derivatized dextran and concanavalin A glucose-responsive materials for closed-loop insulin delivery.

    Sahota, Tarsem / Sawicka, Kirsty / Taylor, Joan / Tanna, Sangeeta

    Drug development and industrial pharmacy

    2011  Volume 37, Issue 3, Page(s) 351–358

    Abstract: Aim: Dextran methacrylate (dex-MA) and concanavalin A (con A)-methacrylamide were photopolymerized to produce covalently cross-linked glucose-sensitive gels for the basis of an implantable closed-loop insulin delivery device.: Methods: The ... ...

    Abstract Aim: Dextran methacrylate (dex-MA) and concanavalin A (con A)-methacrylamide were photopolymerized to produce covalently cross-linked glucose-sensitive gels for the basis of an implantable closed-loop insulin delivery device.
    Methods: The viscoelastic properties of these polymerized gels were tested rheologically in the non-destructive oscillatory mode within the linear viscoelastic range at glucose concentrations between 0 and 5% (w/w).
    Results: For each cross-linked gel, as the glucose concentration was raised, a decrease in storage modulus, loss modulus and complex viscosity (compared at 1 Hz) was observed, indicating that these materials were glucose responsive. The higher molecular weight acrylic-derivatized dextrans [degree of substitution (DS) 3 and 8%] produced higher complex viscosities across the glucose concentration range.
    Conclusions: These studies coupled with in vitro diffusion experiments show that dex-MA of 70 kDa and DS (3%) was the optimum mass average molar mass to produce gels that show reduced component leach, glucose responsiveness, and insulin transport useful as part of a self-regulating insulin delivery device.
    MeSH term(s) Acrylamides/chemistry ; Concanavalin A/chemistry ; Dextrans/chemistry ; Diffusion ; Drug Delivery Systems ; Feedback, Physiological ; Gels ; Glucose/analysis ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/chemistry ; Hypoglycemic Agents/pharmacology ; Infusion Pumps, Implantable ; Insulin/administration & dosage ; Insulin/chemistry ; Methacrylates ; Molecular Weight ; Temperature ; Viscosity
    Chemical Substances Acrylamides ; Dextrans ; Gels ; Hypoglycemic Agents ; Insulin ; Methacrylates ; methacrylated dextran ; Concanavalin A (11028-71-0) ; Glucose (IY9XDZ35W2) ; methacrylamide (K67NG89J77)
    Language English
    Publishing date 2011-01-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 751874-2
    ISSN 1520-5762 ; 0363-9045
    ISSN (online) 1520-5762
    ISSN 0363-9045
    DOI 10.3109/03639045.2010.513983
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: RNA Identification of PRIME Cells Predicting Rheumatoid Arthritis Flares.

    Orange, Dana E / Yao, Vicky / Sawicka, Kirsty / Fak, John / Frank, Mayu O / Parveen, Salina / Blachere, Nathalie E / Hale, Caryn / Zhang, Fan / Raychaudhuri, Soumya / Troyanskaya, Olga G / Darnell, Robert B

    The New England journal of medicine

    2020  Volume 383, Issue 3, Page(s) 218–228

    Abstract: Background: Rheumatoid arthritis, like many inflammatory diseases, is characterized by episodes of quiescence and exacerbation (flares). The molecular events leading to flares are unknown.: Methods: We established a clinical and technical protocol ... ...

    Abstract Background: Rheumatoid arthritis, like many inflammatory diseases, is characterized by episodes of quiescence and exacerbation (flares). The molecular events leading to flares are unknown.
    Methods: We established a clinical and technical protocol for repeated home collection of blood in patients with rheumatoid arthritis to allow for longitudinal RNA sequencing (RNA-seq). Specimens were obtained from 364 time points during eight flares over a period of 4 years in our index patient, as well as from 235 time points during flares in three additional patients. We identified transcripts that were differentially expressed before flares and compared these with data from synovial single-cell RNA-seq. Flow cytometry and sorted-blood-cell RNA-seq in additional patients were used to validate the findings.
    Results: Consistent changes were observed in blood transcriptional profiles 1 to 2 weeks before a rheumatoid arthritis flare. B-cell activation was followed by expansion of circulating CD45-CD31-PDPN+ preinflammatory mesenchymal, or PRIME, cells in the blood from patients with rheumatoid arthritis; these cells shared features of inflammatory synovial fibroblasts. Levels of circulating PRIME cells decreased during flares in all 4 patients, and flow cytometry and sorted-cell RNA-seq confirmed the presence of PRIME cells in 19 additional patients with rheumatoid arthritis.
    Conclusions: Longitudinal genomic analysis of rheumatoid arthritis flares revealed PRIME cells in the blood during the period before a flare and suggested a model in which these cells become activated by B cells in the weeks before a flare and subsequently migrate out of the blood into the synovium. (Funded by the National Institutes of Health and others.).
    MeSH term(s) Adult ; Arthritis, Rheumatoid/blood ; Arthritis, Rheumatoid/genetics ; Arthritis, Rheumatoid/immunology ; B-Lymphocytes/physiology ; Female ; Fibroblasts/metabolism ; Flow Cytometry ; Gene Expression ; Humans ; Male ; Mesenchymal Stem Cells/metabolism ; Middle Aged ; Patient Acuity ; Sequence Analysis, RNA/methods ; Surveys and Questionnaires ; Symptom Flare Up ; Synovial Fluid/cytology
    Language English
    Publishing date 2020-08-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMoa2004114
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory.

    Sawicka, Kirsty / Hale, Caryn R / Park, Christopher Y / Fak, John J / Gresack, Jodi E / Van Driesche, Sarah J / Kang, Jin Joo / Darnell, Jennifer C / Darnell, Robert B

    eLife

    2019  Volume 8

    Abstract: Loss of the RNA binding protein FMRP causes Fragile X Syndrome (FXS), the most common cause of inherited intellectual disability, yet it is unknown how FMRP function varies across brain regions and cell types and how this contributes to disease ... ...

    Abstract Loss of the RNA binding protein FMRP causes Fragile X Syndrome (FXS), the most common cause of inherited intellectual disability, yet it is unknown how FMRP function varies across brain regions and cell types and how this contributes to disease pathophysiology. Here we use conditional tagging of FMRP and CLIP (FMRP cTag CLIP) to examine FMRP mRNA targets in hippocampal CA1 pyramidal neurons, a critical cell type for learning and memory relevant to FXS phenotypes. Integrating these data with analysis of ribosome-bound transcripts in these neurons revealed CA1-enriched binding of autism-relevant mRNAs, and CA1-specific regulation of transcripts encoding circadian proteins. This contrasted with different targets in cerebellar granule neurons, and was consistent with circadian defects in hippocampus-dependent memory in
    MeSH term(s) Animals ; Autistic Disorder/genetics ; Autistic Disorder/metabolism ; Autistic Disorder/physiopathology ; CA1 Region, Hippocampal/cytology ; CA1 Region, Hippocampal/metabolism ; Cerebellum/cytology ; Cerebellum/metabolism ; Circadian Clocks/genetics ; Circadian Clocks/physiology ; Disease Models, Animal ; Fragile X Mental Retardation Protein/genetics ; Fragile X Mental Retardation Protein/metabolism ; Fragile X Syndrome/genetics ; Fragile X Syndrome/metabolism ; Fragile X Syndrome/physiopathology ; Gene Expression Regulation ; Humans ; Memory Disorders/genetics ; Memory Disorders/metabolism ; Memory Disorders/physiopathology ; Mice, Inbred C57BL ; Mice, Knockout ; Neurons/metabolism ; Pyramidal Cells/metabolism
    Chemical Substances Fragile X Mental Retardation Protein (139135-51-6)
    Language English
    Publishing date 2019-12-20
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.46919
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity.

    Moore, Michael J / Blachere, Nathalie E / Fak, John J / Park, Christopher Y / Sawicka, Kirsty / Parveen, Salina / Zucker-Scharff, Ilana / Moltedo, Bruno / Rudensky, Alexander Y / Darnell, Robert B

    eLife

    2018  Volume 7

    Abstract: Dynamic post-transcriptional control of RNA expression by RNA-binding proteins (RBPs) is critical during immune response. ZFP36 RBPs are prominent inflammatory regulators linked to autoimmunity and cancer, but functions in adaptive immunity are less ... ...

    Abstract Dynamic post-transcriptional control of RNA expression by RNA-binding proteins (RBPs) is critical during immune response. ZFP36 RBPs are prominent inflammatory regulators linked to autoimmunity and cancer, but functions in adaptive immunity are less clear. We used HITS-CLIP to define ZFP36 targets in mouse T cells, revealing unanticipated actions in regulating T-cell activation, proliferation, and effector functions. Transcriptome and ribosome profiling showed that ZFP36 represses mRNA target abundance and translation, notably through novel AU-rich sites in coding sequence. Functional studies revealed that ZFP36 regulates early T-cell activation kinetics cell autonomously, by attenuating activation marker expression, limiting T cell expansion, and promoting apoptosis. Strikingly, loss of ZFP36 in vivo accelerated T cell responses to acute viral infection and enhanced anti-viral immunity. These findings uncover a critical role for ZFP36 RBPs in restraining T cell expansion and effector functions, and suggest ZFP36 inhibition as a strategy to enhance immune-based therapies.
    MeSH term(s) Animals ; Antiviral Agents/metabolism ; Base Sequence ; Bone Marrow/virology ; CD4-Positive T-Lymphocytes/metabolism ; Cell Lineage ; Immunity ; Kinetics ; Lymphocyte Activation ; Lymphocytic choriomeningitis virus/physiology ; Mice, Inbred C57BL ; Mice, Knockout ; Protein Biosynthesis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism ; Ribosomes/metabolism ; T-Lymphocytes/metabolism ; Transcriptome/genetics ; Tristetraprolin/genetics ; Tristetraprolin/metabolism
    Chemical Substances Antiviral Agents ; RNA, Messenger ; RNA-Binding Proteins ; Tristetraprolin ; Zfp36 protein, mouse
    Language English
    Publishing date 2018-05-31
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.33057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top